Noriomi Matsumura

Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Junzo Hamanishi, Masaki Mandai, Takafumi Ikeda et al. · Journal of Clinical Oncology · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +17

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi et al. · British Journal of Cancer · 2015 · 709 citations · Full text

Medicine, Immunology, Oncology +17

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng Jin, Junzo Hamanishi, Noriomi Matsumura et al. · Cancer Research · 2015 · 522 citations

Medicine, Immunology, Oncology +17

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

Ruby Yun‐Ju Huang, M. K. Wong, Tuan Zea Tan et al. · Cell Death and Disease · 2013 · 467 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

Tsukasa Baba, P. Convery, Noriomi Matsumura et al. · Oncogene · 2008 · 417 citations

Medicine, Cell Biology, Oncology +14